Search

everythinglearnresearchcommunity

for

Search:↓

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Targeting the Smoothened receptor shows promise for treating certain cancers.

New genetic discoveries may lead to better treatments for alopecia areata.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Hair follicle-derived extracellular vesicles may help heal chronic wounds as effectively as those from adipose tissue.

The model accurately predicts age from saliva and buccal cells for forensic use.

Certain diets may help with hair growth in people with different types of hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

JAK inhibitors show promise for treating various skin diseases.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.